Opinion|Videos|August 21, 2024
CML Treatment: Scenarios that Necessitate Switching Therapy
Jorge E. Cortes, MD, details clinical scenarios that indicate a need to switch therapies for patients with chronic myeloid leukemia.
Advertisement
Episodes in this series
This program was made possible with support from Novartis Pharmaceuticals.
Video content above is prompted by the following:
- In which scenarios do you consider switching CML therapies, and how do you approach that conversation with patients? How does the patient experience change when switching therapies?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Sarclisa Escena as a New Under the Skin Treatment Option for Multiple Myeloma
2
Life After Stage 3B Non-Small Cell Lung Cancer
3
GLP-1s: Weight Loss and Survival in Breast Cancer Recovery
4
FDA Approves Keytruda-Based Combination Before and After Surgery for Muscle-Invasive Bladder Cancer
5